前收市價 | 6.21 |
開市 | 6.25 |
買盤 | 6.75 x 600 |
賣出價 | 6.78 x 600 |
今日波幅 | 5.81 - 6.90 |
52 週波幅 | 1.74 - 6.90 |
成交量 | |
平均成交量 | 1,598,970 |
市值 | 2.086B |
Beta 值 (5 年,每月) | 1.35 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.48 |
業績公佈日 | 2024年2月29日 - 2024年3月04日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 7.25 |
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript November 7, 2023 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.12. Operator: Good morning, and welcome to the Amneal Third Quarter 2013 Earnings Call. I will now turn the call over to Amneal Head of Investor Relations, Anthony DiMeo. Anthony DiMeo: […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2023 Earnings Call Transcript August 4, 2023 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.1. Operator: Hello, everyone and welcome to the Amneal Pharmaceuticals Second Quarter 2023 Earnings Conference Call. My name is Bruno, and I’ll be operating your call today. [Operator Instructions] I will […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2023 Earnings Call Transcript May 5, 2023 Operator: Hello, everyone and welcome to the Amneal Pharmaceuticals First Quarter 2023 Earnings Conference Call. My name is Emily, and I’ll be your moderator for today’s call. I will now turn the call over to Amneal’s Head of Investor Relations, Tony DiMeo. Please […]